Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
Biochemistry
|
January 21, 2000
Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice
K List, O N Jensen, T H Bugge, et al.
Microvascular Research
|
November 3, 2007
Quantification of in vivo tumor invasion and vascularization by computerized image analysis
S Blacher, M Jost, L Melen-Lamalle, et al.
Development (Cambridge, England)
|
January 1, 1996
Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways
L R Lund, J Rømer, N Thomasset, et al.
The Journal of Biological Chemistry
|
September 5, 1992
Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain
G Høyer-Hansen, E Rønne, H Solberg, et al.
Molecular and Cellular Endocrinology
|
January 1, 1989
Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines
B Georg, E Helseth, L R Lund, et al.
Nature Medicine
|
July 1, 1996
Plasminogen and wound healing
J Rømer, T H Bugge, C Pyke, et al.
Nature Medicine
|
March 1, 1996
Impaired wound healing in mice with a disrupted plasminogen gene
J Romer, T H Bugge, C Pyke, et al.
The Journal of Investigative Dermatology
|
November 1, 1991
Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds
J Rømer, L R Lund, J Eriksen, et al.
The Journal of Experimental Medicine
|
September 22, 1998
Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo
A E May, S M Kanse, L R Lund, et al.
Molecular and Cellular Biology
|
August 1, 1987
Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells
P A Andreasen, C Pyke, A Riccio, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
Biochemistry
|
January 21, 2000
Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice
K List, O N Jensen, T H Bugge, et al.
Microvascular Research
|
November 3, 2007
Quantification of in vivo tumor invasion and vascularization by computerized image analysis
S Blacher, M Jost, L Melen-Lamalle, et al.
Development (Cambridge, England)
|
January 1, 1996
Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways
L R Lund, J Rømer, N Thomasset, et al.
The Journal of Biological Chemistry
|
September 5, 1992
Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain
G Høyer-Hansen, E Rønne, H Solberg, et al.
Molecular and Cellular Endocrinology
|
January 1, 1989
Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines
B Georg, E Helseth, L R Lund, et al.
Nature Medicine
|
July 1, 1996
Plasminogen and wound healing
J Rømer, T H Bugge, C Pyke, et al.
Nature Medicine
|
March 1, 1996
Impaired wound healing in mice with a disrupted plasminogen gene
J Romer, T H Bugge, C Pyke, et al.
The Journal of Investigative Dermatology
|
November 1, 1991
Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds
J Rømer, L R Lund, J Eriksen, et al.
The Journal of Experimental Medicine
|
September 22, 1998
Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo
A E May, S M Kanse, L R Lund, et al.
Molecular and Cellular Biology
|
August 1, 1987
Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells
P A Andreasen, C Pyke, A Riccio, et al.
Page
of 7